I really hope I'm not breaking any rules here but this has really been bothering me. Betwen 2010-2020 life expectancy in the United States in 2010–2020 was 43 years[142] and in the UK 67 years. It is common for children born in sub-Saharan Africa to die before the age of 5. Hopefully the new gene therapy will change the life expectance (and quality-of-life) of these patients no matter where they reside, but I want to know (particularly) why the disparity between patients living in two different developed nations. We've changed AIDS and cystic fibrosis from death sentences to manageable disorders effectiing grandmas and grandpas. Why is sickle cell so far behind the pack?   submitted by   /u/melatonia [link]   [comments]